Schizophrenia

The Pharmacy Times® Schizophrenia Resource Center is a comprehensive resource for clinical news and expert insights on treatments for schizophrenia.

Latest News

Medical form, diagnosis schizophrenia | Image Credit: Rawf8 | stock.adobe.com
Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

July 10th 2025

Lumatperone showed a 63% reduction in relapse risk for patients with schizophrenia, promising improved patient stability and care.

Community Pharmacist Collaboration Expands Access to Long-Acting Injectable Antipsychotics
Community Pharmacist Collaboration Expands Access to Long-Acting Injectable Antipsychotics

June 9th 2025

Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia
Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia

May 4th 2025

Depiction of mental illness -- Image credit: tadamichi | stock.adobe.com
How Pharmacies Can Better Support Employees Living With Serious Mental Illness

April 2nd 2025

Video Interviews
Latest CME Events & Activities

More News